The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on December 19, 2025 for Aayush Agrawal, ....
AJANTPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.4 pts more than Nifty Midcap 150 and 0.9 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Promoter Aayush M. Agrawal (trustee of Aayush Agrawal Trust) disclosed creation of a pledge on 6,38,500 shares (0.51% of share capital) in favor of Bajaj Finance Ltd on 11-Dec-2025, citing an increased loan. Separately, a pledge on 4,50,000 shares (0.36%) earlier held with Infina Finance Ltd was released on 16-Dec-2025 due to loan repayment. Net effect is a fresh pledge of 1,88,500 additional shares, taking the trust's total encumbered holding to 65,18,247 shares (5.22% of share capital) post-event.
Mildly negative optic — incremental pledging signals fresh promoter borrowings against holdings, though the simultaneous release shows active deleveraging. Investors should watch for further pledge actions or any invocation events going forward.